35005-30-2Relevant articles and documents
Bio-based aromatic copoly(ether ester)s with enhanced toughness and degradability: Influence of insertion of phenoxy-ether linkage and eugenol-derived composition on properties
Hu, Keling,Zhao, Dongping,Wu, Guolin,Ma, Jianbiao
, p. 2171 - 2183 (2016)
Two series of renewable nipagin and eugenol-based copoly(ether ester)s, PDN11-xE1x and PDN11-xE2x (x = 0%, 10%, 20%, 30%, 40%, 50%), were prepared in the melt with 1,10-decanediol as a como
Aryl alkyl ether compound as well as derivative, preparation method, pharmaceutical composition and application thereof
-
Paragraph 0093; 0094; 0095; 0096, (2021/05/12)
The invention discloses an aryl alkyl ether compound as well as a derivative, a preparation method, a pharmaceutical composition and application thereof. The structure of the aryl alkyl ether compound is shown as a formula (I). The aryl alkyl ether compound derivative relates to a stereoisomer, a tautomer, a metabolite, a metabolic precursor, a prodrug, a solvate, a salt of the solvate, a crystal, a pharmaceutically acceptable salt or a mixture of the stereoisomer, the tautomer, the metabolite, the metabolic precursor, the prodrug and the solvate of the aryl alkyl ether compound. The aryl alkyl ether compound and the derivative thereof have a remarkable inhibition effect on indoleamine 2, 3-dioxygenase 1, and can be used for preparing a medicine for treating indoleamine 2, 3-dioxygenase 1 mediated immunosuppression related diseases, and the prepared medicine can exert the medicine effect at the molecular level and is wide in application.
Synthesis and antiviral activity of new bisacridinylhydrazides of aryloxyacetic acids
Lyakhov,Lyakhova,Panchenko,Litvinova,Andronati
, p. 653 - 656 (2007/10/03)
-
